What is Eton Pharmaceuticals, Inc.'s revenue?

Eton Pharmaceuticals, Inc. (ETON) reported revenue of $24.27M in Q1 2026.

How has Eton Pharmaceuticals, Inc.'s revenue changed year-over-year?

Eton Pharmaceuticals, Inc.'s revenue increased by 40.4% year-over-year, from $17.28M to $24.27M.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s revenue?

Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s revenue has grown at a 38.3% compound annual growth rate (CAGR), from $21.83M to $79.95M.

Eton Pharmaceuticals, Inc. ETON Revenue

Revenue at other companies

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

Ollie's Bargain Outlet Holdings, Inc.OLLI

$658.93M+14.2%

PhotronicsPLAB

$209.94M-0.5%

First BanCorpFBP

$258.64M+4.2%

Other financials

Income statement

See full

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

See full

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

See full

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

See full

Market cap$930.79M+162%

Enterprise value$942.39M+156%

P/S10.7×+3.4×

Profitability

See full

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

See full

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s revenue?: Eton Pharmaceuticals, Inc. (ETON) reported revenue of $24.27M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s revenue changed year-over-year?: Eton Pharmaceuticals, Inc.'s revenue increased by 40.4% year-over-year, from $17.28M to $24.27M.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s revenue?: Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s revenue has grown at a 38.3% compound annual growth rate (CAGR), from $21.83M to $79.95M.